Makoto Endo

Dr. Makoto Endo

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
MEMakoto Endo
Makoto Endo
HOHiroyuki Oizumi
Hiroyuki Oizumi
HKHirohisa Kato
Hirohisa Kato
JSJun Suzuki
Jun Suzuki
HWHikaru Watarai
Hikaru Watarai
MSMitsuaki Sadahiro
Mitsuaki Sadahiro

1 April 2011
Verified
Journal Article
Closed access
NYNaoki Yanagawa
Naoki Yanagawa
GTGen Tamura
Gen Tamura
HOHiroyuki Oizumi
Hiroyuki Oizumi
MEMakoto Endo
Makoto Endo
MSMitsuaki Sadahiro
Mitsuaki Sadahiro
TMTeiichi Motoyama
Teiichi Motoyama

1 August 2016 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
MEMakoto Endo
Makoto Endo
HOHiroyuki Oizumi
Hiroyuki Oizumi
NKNaoki Kanauchi
Naoki Kanauchi
HKHirohisa Kato
Hirohisa Kato
HOHiroshi Ota
Hiroshi Ota
MSMitsuaki Sadahiro
Mitsuaki Sadahiro

19 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Yoshikane YamauchiYoshikane Yamauchi
Yoshikane Yamauchi
HAHiroyuki Adachi
Hiroyuki Adachi
NTNobumasa Takahashi
Nobumasa Takahashi
TMTakao Morohoshi
Takao Morohoshi
TYTaketsugu Yamamoto
Taketsugu Yamamoto
NSNoriyoshi Sawabata
Noriyoshi Sawabata
Objectives: The choice of therapeutic intervention for postoperative air leak varies between institutions. We aimed to identify the optimal timing and patient criteria for therapeutic intervention in cases of postoperative air leaks after lung resection. Methods: This study utilized data from a prospective multicenter observational study conducted in 2019. Among the 2187 cases in the database, 420 cases with air leaks on postoperative day 1 were identified. The intervention group underwent therapeutic interventions, such as pleurodesis or surgery, while the observation group was monitored without intervention. A comparison between the intervention group and the observation group were analyzed using the cumulative distribution and hazard functions. Results: Forty-six patients (11.0%) were included in the intervention group. The multivariate analysis revealed that low body mass index (p = 0.019), partial resection (p = 0.010), intraoperative use of fibrin glue (p = 0.008), severe air leak on postoperative day 1 (p < 0.001), and high forced expiratory volume in 1 s (p = 0.021) were significant predictors of the requirement for intervention. The proportion of patients with persistent air leak in the observation group was 20% on postoperative day 5 and 94% on postoperative day 7. The hazard of air leak cessation peaked from postoperative day 3 to postoperative day 7. Conclusions: This research contributes valuable insights into predicting therapeutic interventions for postoperative air leaks and identifies scenarios where spontaneous cessation is probable. A validation through prospective studies is warranted to affirm these findings.

10 November 2023 in Japanese Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
Shinkichi TakamoriShinkichi Takamori
Shinkichi Takamori
YYYasushi Yatabe
Yasushi Yatabe
AOAtsushi Osoegawa
Atsushi Osoegawa
KAKeiju Aokage
Keiju Aokage
HYHiroshige Yoshioka
Hiroshige Yoshioka
SWShun-Ichi Watanabe
Shun-Ichi Watanabe
Salivary gland-type tumor (SGT) of the lung, which arises from the bronchial glands of the tracheobronchial tree, was first recognized in the 1950s. SGT represents less than 1% of all lung tumors and is generally reported to have a good prognosis. Mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (ACC) are the two most common subtypes, comprising more than 90% of all SGTs. The reported 5-year survival rate of patients with SGT is 63.4%. Because this type of tumor develops in major bronchi, patients with SGT commonly present with symptoms of bronchial obstruction, including dyspnea, shortness of breath, wheezing, and coughing; thus, the tumor is usually identified at an early stage. Most patients are treated by lobectomy and pneumonectomy, but bronchoplasty or tracheoplasty is often needed to preserve respiratory function. Lymphadenectomy in the surgical resection of SGT is recommended, given that clinical benefit from lymphadenectomy has been reported in patients with MEC. For advanced tumors, appropriate therapy should be considered according to the subtype because of the varying clinicopathologic features. MEC, but not ACC, is less likely to be treated with radiation therapy because of its low response rate. Although previous researchers have learned much from studying SGT over the years, the diagnosis and treatment of SGT remains a complex and challenging problem for thoracic surgeons. In this article, we review the diagnosis, prognosis, and treatment (surgery, chemotherapy, and radiotherapy) of SGT, mainly focusing on MEC and ACC. We also summarize reports of adjuvant and definitive radiation therapy for ACC in the literature.

1 January 2011
Verified
Journal Article
Closed access
NYNaoki Yanagawa
Naoki Yanagawa
GTGen Tamura
Gen Tamura
HOHiroyuki Oizumi
Hiroyuki Oizumi
MEMakoto Endo
Makoto Endo
TMTeiichi Motoyama
Teiichi Motoyama